<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02281721</url>
  </required_header>
  <id_info>
    <org_study_id>T4029</org_study_id>
    <nct_id>NCT02281721</nct_id>
  </id_info>
  <brief_title>Surpass Flow Diverter for Intracranial Aneurysms: SURMOUNT Registry Data Collection</brief_title>
  <official_title>Prospective, Observational, Multi-Center, Single-Arm, Consecutive Enrollment, Post-Marketing, International Registry of the Surpass™ Flow Diverter in Intracranial Arteries</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stryker Neurovascular</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stryker Neurovascular</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this observational post-marketing registry will be to collect and analyze
      safety, effectiveness, and quality of life outcomes, during and after treatment with the
      Surpass Flow Diverter. Health Economics assessments (cost data) will also be collected and
      analyzed.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This will be a prospective, observational, multi-center, single-arm, post-marketing,
      international registry with consecutive enrollment of a minimum of 150 patients treated with
      the Surpass Flow Diverter in accordance with the standard of care at up to 30 registry sites.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2015</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>5 Years</target_duration>
  <primary_outcome>
    <measure>Primary effectiveness based on the proportion of patients with 100% aneurysm occlusion</measure>
    <time_frame>12 months</time_frame>
    <description>The proportion of patients with 100% aneurysm occlusion, based on an assessment of each patient's imaging at 12 months (± 180 days) post-procedure, and stratified across four aneurysm categories.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Technical success assessed by deployment of the device with complete coverage of the aneurysm neck</measure>
    <time_frame>Peri-procedural</time_frame>
    <description>Successful deployment of the device with complete coverage of the aneurysm neck.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Safety outcomes assessed by neurological adverse events</measure>
    <time_frame>Up to 5 years</time_frame>
    <description>Neurological adverse events</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Cerebral Aneurysm</condition>
  <arm_group>
    <arm_group_label>Single Group; Surpass Flow Diverter(s)</arm_group_label>
    <description>Individuals using the Surpass Flow Diverter(s)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Surpass Flow Diverter(s)</intervention_name>
    <description>Endovascular placement of a Surpass Flow Diverter(s) for the treatment of an intracranial aneurysm(s)</description>
    <arm_group_label>Single Group; Surpass Flow Diverter(s)</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        For the primary endpoint, the evaluable patient population will consist of all individuals
        treated with the Surpass Flow Diverter(s) who have provided consent, and who have completed
        their 12 month follow-up assessment.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who are to be treated with a Surpass Flow Diverter(s) will be eligible to
             participate in this registry. Patients will be enrolled on a consecutive basis.

        Exclusion Criteria:

          -  This is a standard of care registry. Patients should be excluded if standard of care
             at a given site is such that they are not eligible for treatment with a Surpass Flow
             Diverter(s).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Patrick A Brouwer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Karolinska Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Caroline Le Page</last_name>
    <email>caroline.lepage@stryker.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Doug Follett, DVM</last_name>
    <email>doug.follett@stryker.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>AZ groeninge</name>
      <address>
        <city>Kortrijk</city>
        <zip>8500</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Olivier François</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Helsinki University Hospital</name>
      <address>
        <city>Helsinki</city>
        <zip>00260</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sari Sainio</last_name>
      <email>sari.sainio@hus.fi</email>
    </contact>
    <contact_backup>
      <last_name>Veera Lotvonen</last_name>
      <email>veera.lotvonen@hus.fi</email>
    </contact_backup>
    <investigator>
      <last_name>Jussi Numminen</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Turun yliopistollinen keskussairaala</name>
      <address>
        <city>Turku</city>
        <zip>20521</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hopital Jean Minjoz</name>
      <address>
        <city>Besançon</city>
        <zip>25030</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alessandra Biondi, PhD, MD</last_name>
      <email>biondi.alessandra@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Christelle Cappe, Study CO</last_name>
      <email>ccappe@chu-besancon.fr</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>APHP - Kremlin Bicêtre</name>
      <address>
        <city>Le Kremlin-Bicêtre</city>
        <zip>94270</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurent Spelle</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Fondation Rothschild</name>
      <address>
        <city>Paris</city>
        <zip>75020</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michel Piotin, PhD, MD</last_name>
      <email>mpiotin@free.fr</email>
    </contact>
    <contact_backup>
      <last_name>Marie Abrivard, Study Co</last_name>
      <email>mabrivard@fo-rothschild.fr</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hopital Bretonneau</name>
      <address>
        <city>Tours</city>
        <zip>37 000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna-Paula Narata, MD</last_name>
      <email>ana-paula.narata@chu-tours.fr</email>
    </contact>
    <contact_backup>
      <last_name>Vladimir Charron, Study Co</last_name>
      <email>v.charron@chu-tours.fr</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Freiburg University Hospital</name>
      <address>
        <city>Freiburg</city>
        <zip>79085</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Taschner, PhD, MD</last_name>
      <email>christian.taschner@uniklinik-freiburg.de</email>
    </contact>
    <contact_backup>
      <last_name>Ulrike Bergmann, Study Co</last_name>
      <email>ulrike.bergmann@uniklinik-freiburg.de</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Klinikum Kassel</name>
      <address>
        <city>Kassel</city>
        <zip>34125</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ralph Siekmann</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsmedizin Mannheim</name>
      <address>
        <city>Mannheim</city>
        <zip>68167</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christoph Groden</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>San Martino Hospital</name>
      <address>
        <city>Genova</city>
        <zip>16132</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Lucio Casrellan</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Neuroradiologia Azienda ILSS9</name>
      <address>
        <city>Treviso</city>
        <zip>31100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Radboudumc</name>
      <address>
        <city>Nijmegen</city>
        <zip>6500</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joost de Vries</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Clinic de Barcelona</name>
      <address>
        <city>Barcelona</city>
        <zip>08036</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Juan Macho, MD</last_name>
      <email>jmmacho@clinic.us.es</email>
    </contact>
    <contact_backup>
      <last_name>Jordi Blasco, MD</last_name>
      <email>jblasco@clinic.ub.es</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Marques de Valdecilla</name>
      <address>
        <city>Santander</city>
        <zip>39008</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andres Gonzalez, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Karolinska University Hospital in Solna, Department of Neuroradiology</name>
      <address>
        <city>Stockholm</city>
        <zip>171 16</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patrick Brouwer, MD, PhD</last_name>
      <phone>+46 72 582 32 82</phone>
    </contact>
    <contact_backup>
      <last_name>Åke Holmberg</last_name>
      <phone>+46-8-517 707 16</phone>
      <email>ake.holmberg@karolinska.se</email>
    </contact_backup>
    <investigator>
      <last_name>Patrik Brouwer, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Queen's Hospital of Romford, NHS Barking, Havering and Redbridge University Hospitals Trust</name>
      <address>
        <city>Romford</city>
        <state>Essex</state>
        <zip>RM7 0AG</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shahram Derakhshani, MD</last_name>
      <phone>0044 170 843 5000</phone>
      <email>s.derakhshani@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Shahram Derakhshani, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Queen Elizabeth Hospital</name>
      <address>
        <city>Birmingham</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Saleh Lamin</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Walton center</name>
      <address>
        <city>Liverpool</city>
        <zip>L9 7LJ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hans Nahser, MD</last_name>
      <phone>00441515295471</phone>
      <email>hans.nahser@thewaltoncentre.nhs.uk</email>
    </contact>
    <contact_backup>
      <last_name>Imelda O'Brien, RN</last_name>
      <phone>00441515295471</phone>
      <email>Imelda.O'Brien@thewaltoncentre.nhs.uk</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Finland</country>
    <country>France</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Netherlands</country>
    <country>Spain</country>
    <country>Sweden</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 30, 2014</study_first_submitted>
  <study_first_submitted_qc>October 31, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 3, 2014</study_first_posted>
  <last_update_submitted>January 4, 2018</last_update_submitted>
  <last_update_submitted_qc>January 4, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 8, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Intracranial Aneurysm</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Calcium Carbonate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

